Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Mimedx Group (MDXG) Gross Profit: 2011-2025

Historic Gross Profit for Mimedx Group (MDXG) over the last 15 years, with Sep 2025 value amounting to $95.0 million.

  • Mimedx Group's Gross Profit rose 38.22% to $95.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $322.6 million, marking a year-over-year increase of 12.87%. This contributed to the annual value of $288.8 million for FY2024, which is 8.23% up from last year.
  • Per Mimedx Group's latest filing, its Gross Profit stood at $95.0 million for Q3 2025, which was up 18.87% from $79.9 million recorded in Q2 2025.
  • Mimedx Group's 5-year Gross Profit high stood at $95.0 million for Q3 2025, and its period low was $43.7 million during Q4 2021.
  • Its 3-year average for Gross Profit is $72.9 million, with a median of $71.7 million in 2024.
  • As far as peak fluctuations go, Mimedx Group's Gross Profit declined by 24.28% in 2021, and later spiked by 38.22% in 2025.
  • Over the past 5 years, Mimedx Group's Gross Profit (Quarterly) stood at $43.7 million in 2021, then spiked by 37.27% to $60.0 million in 2022, then climbed by 21.64% to $73.0 million in 2023, then rose by 4.12% to $76.0 million in 2024, then skyrocketed by 38.22% to $95.0 million in 2025.
  • Its Gross Profit stands at $95.0 million for Q3 2025, versus $79.9 million for Q2 2025 and $71.6 million for Q1 2025.